Pedro Rodrigues Genta

Pedro Rodrigues Genta

Auto-generated profile, based on publicly available information

Pedro Rodrigues Genta

Unidade de Disturbios do Sono, Divisao de Pneumologia, Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Journal of Clinical Sleep Medicine
Verified
Journal Article
Closed access
FGFelipe Dias Genta
Felipe Dias Genta
GNGuilherme Brito Rodrigues Neto
Guilherme Brito Rodrigues Neto
JSJoão Pedro Velletri Sunfeld
João Pedro Velletri Sunfeld
JPJoão Fabio Porto
João Fabio Porto
AXAndressa Dallago Xavier
Andressa Dallago Xavier
PGPedro Rodrigues Genta
Pedro Rodrigues Genta
Study Objectives:The COVID-19 pandemic has challenged the population of affected areas in multiple dimensions. Adolescents have been especially affected with school closure and home confinement. Th...

1 October 2020 in Annals of the American Thoracic Society
Verified
Journal Article
Open access
PGPedro R. Genta
Pedro R. Genta
MKMarta Kaminska
Marta Kaminska
BEBradley A. Edwards
Bradley A. Edwards
MEMatthew R. Ebben
Matthew R. Ebben
AKAna C. Krieger
Ana C. Krieger
PSPatrick Strollo
Patrick Strollo
Continuous positive airway pressure (CPAP) remains the major treatment option for obstructive sleep apnea (OSA). The American Thoracic Society organized a workshop to discuss the importance of mask selection for OSA treatment with CPAP. In this workshop report, we summarize available evidence about the breathing route during nasal and oronasal CPAP and the importance of nasal symptoms for CPAP outcomes. We explore the mechanisms of air leaks during CPAP treatment and possible alternatives for leak control. The impact of nasal and oronasal CPAP on adherence, residual apnea–hypopnea index, unintentional leaks, and pressure requirements are also compared. Finally, recommendations for patient and partner involvement in mask selection are presented, and future directions to promote personalized mask selection are discussed.

1 November 2011 in Journal of Applied Physiology
Verified
Journal Article
Open access
PDF file
PGPedro R. Genta
Pedro R. Genta
DEDanny J. Eckert
Danny J. Eckert
MGMarcelo G. Gregorio
Marcelo G. Gregorio
NDNaury J. Danzi
Naury J. Danzi
HMHenrique T. Moriya
Henrique T. Moriya
GLGeraldo Lorenzi-Filho
Geraldo Lorenzi-Filho
The critical closing pressure (Pcrit) is the airway pressure at which the airway collapses and reflects the anatomical contribution to the genesis of obstructive sleep apnea. Pcrit is usually determined during non-rapid eye movement sleep at night, but has been determined under midazolam sedation during the day in the absence of sleep stage monitoring. Indeed, little is known about the effects of midazolam on sleep architecture. Moreover, deeper sedation with midazolam can decrease upper airway muscle activity and increase collapsibility compared with natural sleep. Pcrit under sedation has not been systematically compared with the usual method performed during natural sleep. Therefore, this study aimed to test the hypothesis that Pcrit following low doses of midazolam during the day would be comparable to Pcrit measured during natural sleep in the same patient. Fifteen men (age 54 ± 10 yr, body mass index 30 ± 4 kg/m2) with obstructive sleep apnea underwent a baseline standard overnight polysomnogram (apnea-hypopnea index 38 ± 22 events/h, range: 8–66 events/h), and Pcrit was determined during natural sleep and following midazolam. Sleep induction was obtained with low doses of midazolam (2.4 mg, range 2.0–4.4 mg), and sleep architecture was comparable to natural sleep. Natural sleep and induced sleep Pcrit were similar (−0.82 ± −3.44 and −0.97 ± 3.21 cmH2O, P = 0.663) and closely associated (intraclass correlation coefficient = 0.92; 95% confidence interval, 0.78–0.97, P < 0.001). Natural and midazolam-induced Pcrit correlated with obstructive sleep apnea severity, indicating that both Pcrit measures provided meaningful physiological information. Pcrit determined during the day with sleep induction is similar to natural overnight sleep and is a valid alternative approach in which to determine Pcrit.

1 December 2018 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PDF file
RARodolfo Augusto Bacelar de Athayde
Rodolfo Augusto Bacelar de Athayde
JFJosé Ricardo Bandeira de Oliveira Filho
José Ricardo Bandeira de Oliveira Filho
GFGeraldo Lorenzi Filho
Geraldo Lorenzi Filho
PGPedro Rodrigues Genta
Pedro Rodrigues Genta
Obesity hypoventilation syndrome (OHS) is defined as the presence of obesity (body mass index ≥ 30 kg/m²) and daytime arterial hypercapnia (PaCO2 ≥ 45 mmHg) in the absence of other causes of hypoventilation. OHS is often overlooked and confused with other conditions associated with hypoventilation, particularly COPD. The recognition of OHS is important because of its high prevalence and the fact that, if left untreated, it is associated with high morbidity and mortality. In the present review, we address recent advances in the pathophysiology and management of OHS, the usefulness of determination of venous bicarbonate in screening for OHS, and diagnostic criteria for OHS that eliminate the need for polysomnography. In addition, we review advances in the treatment of OHS, including behavioral measures, and recent studies comparing the efficacy of continuous positive airway pressure with that of noninvasive ventilation.

15 February 2023 in Sleep Medicine
Verified
Journal Article
Closed access
GDGiovanna F. D'ANgelo
Giovanna F. D'ANgelo
AMAndré A.F. de Mello
André A.F. de Mello
FSFabiola Schorr
Fabiola Schorr
EGEloisa Gebrim
Eloisa Gebrim
MFMariana Fernandes
Mariana Fernandes
PGPedro Rodrigues Genta
Pedro Rodrigues Genta

1 October 2023 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
EBElliot J. Brooker
Elliot J. Brooker
SLShane Landry
Shane Landry
LTLuke D. J. Thomson
Luke D. J. Thomson
GHGarun S. Hamilton
Garun S. Hamilton
PGPedro R. Genta
Pedro R. Genta
BEBradley Edwards
Bradley Edwards
Rationale: With up to 40% of individuals with either insomnia or obstructive sleep apnea (OSA) demonstrating clinically significant symptoms of the other disorder, the high degree of comorbidity among the two most common sleep disorders suggests a bidirectional relationship and/or shared underpinnings. Although the presence of insomnia disorder is believed to influence the underlying pathophysiology of OSA, this influence is yet to be examined directly. Objectives: To investigate whether the four OSA endotypes (upper airway collapsibility, muscle compensation, loop gain, and the arousal threshold) are different in patients with OSA with and without comorbid insomnia disorder. Methods: Using the ventilatory flow pattern captured from routine polysomnography, the four OSA endotypes were measured in 34 patients with OSA who met the diagnostic criteria for insomnia disorder (COMISA) and 34 patients with OSA without insomnia (OSA only). Patients demonstrated mild-to-severe OSA (apnea–hypopnea index, 25.8 ± 2.0 events/h) and were individually matched according to age (50.2 ± 1.5 yr), sex (42 male: 26 female), and body mass index (29.3 ± 0.6 kg/m2). Results: Compared with patients with OSA without comorbid insomnia, patients with COMISA demonstrated significantly lower respiratory arousal thresholds (128.9 [118.1 to 137.1] vs. 147.7 [132.3 to 165.0] % eupneic ventilation (V̇eupnea); U = 261; 95% confidence interval [CI], −38.3 to −13.9; d = 1.1; P < 0.001), less collapsible upper airways (88.2 [85.5 to 94.6] vs. 72.9 [64.7 to 79.2] % V̇eupnea; U = 1081; 95% CI, 14.0 to 26.7; d = 2.3; P < 0.001), and more stable ventilatory control (i.e., lower loop gain: 0.51 [0.44 to 0.56] vs. 0.58 [0.49 to 0.70]; U = 402; 95% CI, −0.2 to −0.01; d = 0.05; P = 0.03). Muscle compensation was similar between groups. Moderated linear regression revealed that the arousal threshold moderated the relationship between collapsibility and OSA severity in patients with COMISA but not in patients with OSA only. Conclusions: A low arousal threshold is an overrepresented endotypic trait in individuals with COMISA and may exhibit a greater relative contribution to OSA pathogenesis in these patients. Contrastingly, the prevalence of a highly collapsible upper airway in COMISA was low, suggesting that anatomical predisposition may contribute less to OSA development in COMISA. Based on our findings, we theorize that conditioned hyperarousal perpetuating insomnia may translate to a reduced arousal threshold to respiratory events, thereby increasing the risk or severity of OSA. Therapies that target increased nocturnal hyperarousal (e.g., through cognitive behavior therapy for insomnia) may be effective in individuals with COMISA. Clinical trial registered with the Australian and New Zealand Clinical Trial Registry (ACTRN12616000586415).